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Interleukin 2  is a  single polypeptide that functions as a  growth factor for T 
and  B  cells (1-7).  The  cell  growth  signal  induced by  IL-2  is  transduced  via 
specific receptors on the cell surface (8).  Recently, two distinct IL-2-R with high 
and low affinities for IL-2  were identified in  human T  and B cells, as well as 
murine T  cells (9,  10). The mitogenic activity of IL-2 is transmitted via the high- 
affinity receptor (11-13), but little information is available about the mechanism 
of signal  transmission  from  the  IL-2-R.  Hormones  and  other  peptides  are 
internalized into cells by endocytosis after binding to specific receptors on the 
cell  surface  (14-21).  Internalization  is  the  way  to  transport  ligands  such  as 
transferrin (21) and low density lipoprotein (LDL) ~ (17), into the cytoplasm for 
use in the cell. Internalization of epidermal growth factor (EGF) (16, 22), platelet- 
derived growth  factor  (14),  transferrin  (21),  insulin  (23,  24),  and  LDL  (17) 
appears to be essential for degradation and recycling of these ligands or their 
receptors.  Furthermore, internalization of EGF and insulin  may be related to 
triggering of the growth signal of appropriate cells (25-28),  although protein 
kinase activity associated with the receptors is also thought to be involved in the 
mechanism of signal transduction (29). 
After binding  to  specific receptors,  IL-2  is  internalized and then degraded 
(11, 30), but the mechanism of its internalization is unknown. Herein, we examine 
in detail the internalization and metabolic fate of IL-2 in various human cells. 
For this study, we used human T  cell leukemia/lymphoma (lymphotrophic) virus 
type I  (HTLV-I)-carrying human  cell  lines  and  PHA-treated  PBL.  HTLV-I- 
carrying T  and  B  cell  lines  express  IL-2-R  constitutively without  stimulation 
from antigens and mitogens (31,  32),  and we previously (33) showed that  the 
constitutive expression of IL-2-R was induced by HTLV-I infection. Since these 
cell lines can be classified into at  least three groups with respect to their IL-2 
reactivities, e.g., those with IL-2-dependent growth, IL-2-independent growth, 
and IL-2-mediated inhibition of growth (34), they were thought to be useful for 
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studies on normal and abnormal transduction of growth signals, which are elicited 
with  or  without  IL-2-binding  to  receptors,  respectively.  We  report  that  IL-2 
bound to high-affinity receptors was rapidly internalized and degraded depend- 
ent on temperature in these human cells. 
Material and  Methods 
Cell Lines.  The origins, surface phenotypes, and characterization of IL-2-R of the cell 
lines used here were described previously (32). The ILT-Yan cell line is an IL-2-dependent 
cell line carrying HTLV-I. The TL-Mor cell line is an immortalizing transformed T  cell 
line induced by HTLV-I. The MT-1 cell line carrying HTLV-I was established by Miyoshi 
et al. (35).  PBL from a normal donor were treated with  1.0% PHA-M for 3 d  in vitro. 
TL-Mor and MT-1 cells were maintained in RPMI 1640 medium supplemented with 10% 
FCS, 2 mM L-glutamine, and antibiotics. ILT-Yan cells were maintained in RPMI  1640 
medium supplemented with  20%  FCS,  2  mM L-glutamine, antibiotics,  and  250 Jurkat 
U/ml of human rlL-2 (Shionogi Co., Osaka, Japan). 
Before treatment with IL-2, the ceils were always washed twice with PBS and incubated 
in RPMI 1640 medium containing 20% FCS and 25 mM Hepes (RPMI-Hepes) for 1 h at 
37°C. 
Radiolabeling  oflL-2,  rIL-2 was iodinated  by the chloramine T  method as reported 
previously (33).  The specific activity of ~SI-labeled IL-2 was 5.9-8.8  ×  105 cpm/pmol. 
The bioactivity of the rIL-2 was not significantly different from Jurkat-derived IL-2, and 
little affected by iodination. 
3H-labeled rIL-2 was prepared in a cell-free system of rabbit reticulocyte lysate (Amer- 
sham  Corp.,  Buckinghamshire,  United  Kingdom)  with  L-4,5-[3H]leucine  (Amersham 
Corp.). The plasmid used in the transcription-translation system contained a gene coding 
for human  IL-2 (36).  The polypeptide synthesized  was confirmed to be IL-2 by SDS- 
PAGE. The specific activity of ~H-labeled IL-2 was ~1.6 x  106 cpm/nmol. 
IL-2 Binding Assay.  IL-2 binding was measured by a  modification of the SH-labeled 
anti-Tac antibody binding assay reported by Depper et al. (37).  Samples of 5-10 X  105 
cells were suspended in  120/~1  of chilled  I-IL-2 samples, which were serially diluted 
with RPMI-Hepes containing 0.02% sodium azide in wells of microplates (3911;  Falcon 
Labware,  Oxnard  CA).  The microplates were shaken  for 30  min at 4°C  and  further 
incubated at 4°C  for  1 h.  The supernatant  (A) was harvested, and  the cell pellet was 
gently resuspended in  100 ol of PBS. The cell suspension was then layered on 750 t~l of 
RPMI  1640  medium  containing  1  M  sucrose and  0.02%  BSA  in  a  microtube (IEDA 
Trading Corp., Tokyo, Japan). After centrifugation at 12,000 rpm for 3 min at 4°C, the 
supernatant (B) and cell precipitate were harvested. The radioactivities of the supernatant 
(A +  B) and precipitated cells were counted. The specific binding of ~esI-IL-2 to cells was 
calculated by subtracting the count of samples added with excess unlabeled IL-2 (>2 #M) 
for binding competition from the observed count. The count of samples with unlabeled 
IL-2 was always <30% of the observed count. Dissociation constants (Ka) and number of 
binding sites were calculated from Scatchard plots by the NONLIN program of Metzler 
and McEwen (38). The IL-2 binding assay was done in duplicate. 
Acid Treatment of Cell-bound  IL-2.  Acid treatment was used to remove IL-2 attached 
to the cell surface. Cells (2 x  10 ~) were incubated with 200 pM ~25I-IL-2 in RPMI-Hepes 
at 0°C on ice for 30 min. They were then washed three times with PBS containing 3% 
BSA, resuspended in 1.0 ml of glycine-HCI buffer or RPMI-Hepes, and incubated for 10 
min at 0°C on ice. After centrifugation, the radioactivities of the acid-removable glycine 
buffer fraction and acid-unremovable cell precipitate fraction were each counted. 
Determination  of Internalized and Degraded IL-2.  Cells (2  ×  10  ~) were incubated with 
200  pM  125I-IL-2 in  RPMI-Hepes at 0°C  on ice for 30  min.  Then they were washed 
three times with PBS-BSA, resuspended in  1.0 ml RPMI-Hepes, and incubated at 37°C 
in  a  water  bath  for the  indicated  time.  The  suspension  was  centrifuged,  the  culture 
supernatant was harvested, and the cell pellet was then treated with chilled 0.2 M glycine 
buffer (pH 2.8) for 10 min at 0°C on ice.  The radioactivities of the culture supernatant 552  INTERLEUKIN 2  INTERNALIZATION 
fraction,  acid-removable  glycine buffer  fraction,  and  acid-unremovable cell  precipitate 
were each counted. For determination  of degradation of ~25I-IL-2, these fractions were 
further  treated  with  10%  TCA in  the  presence  of 1 mg/ml  BSA overnight at  4°C as 
described previously (11). The radioactivities of the TCA-soluble and -insoluble materials 
were counted separately. 
Light-microscopic Detection of Internalized IL-2.  For light-microscopic autoradiography, 
cells  were  treated  with  1  nM  [3H]IL-2 at  0°C  for  30  min.  They  were  then  washed, 
resuspended  in  1.0  ml  RPMI-Hepes,  and  incubated  at  37°C  for  the  indicated  time. 
Subsequently, they were fixed in 2% glutaraldehyde in PBS for 1 h, washed three times 
with PBS, and postfixed in  1% osmium tetraoxide  for  1 h. All these steps were carried 
out at 4 ° C. The materials were then dehydrated in a graded ethanol series and embedded 
in Epon-Araldite. Thick (2 t~m) sections were cut on a Porter-Blum MT-5000 ultramicro- 
tome  with  glass  knives.  The  sections  were  placed  on  glass  slides  and  were  coated  by 
dipping in Sakura NR-M2 emulsion. The sections were exposed at 4°C for 2 wk. After 
development with  Kodak D19  for 4  rain,  the  sections were stained  with toluidine blue 
and examined by a light microscopy (Nikon, Tokyo, Japan). 
Silver grains in  sections were counted under light  microscope. Silver grains in three 
portions, the cell surface, the cytoplasm, and the nucleus, were counted separately. 
Result 
Scatchard Plot Analysis oflL-2-R.  125I-IL-2  binding assays were performed to 
determine the density and affinity of IL-2-R expressed on various human cells, 
as described in  Materials and  Methods.  Both  high- and  low-affinity receptors 
were detected on two HTLV-I-carrying T  cell lines, ILT-Yan and TL-Mor, and 
on PHA-treated normal PBL (Fig.  1).  In contrast, HTLV-I-carrying MT-1  cell 
line expressed predominantly low-affinity receptors, with very few high-affinity 
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Scatchard  plot analysis of binding of 12~I-labeled IL-2. 1~5I-IL-2 binding assays 
were performed as described  in Materials and Methods. FUJII  ET  AL.  553 
receptors in the culture conditions used (Fig.  1). The Kd of high- and low-affinity 
receptors were estimated by computer analysis as 7.6-16.8  pM and  20.9-64.2 
nM, respectively (Table I). The densities of high-affinity receptors ranged from 
1,240  to  1,630  sites/ceil,  and  were  not  significantly  different  on  HTLV-I- 
carrying T  cells and PHA-treated PBL (Table I), but the densities of low-affinity 
receptors on  the  three  HTLV-I-carrying T  cell  lines  were  5-10  times  higher 
(201,000-560,000  sites/cell)  than  on  the  PHA-treated  PBL (49,000  sites/cell; 
Table I). 
Effect of Acid Treatment on Cell-bound  IL-2.  We used acid treatment to distin- 
guish surface-bound IL-2 from intracellular IL-2. ILT-Yan cells were incubated 
with 200 pM  I25I-IL-2 at 0°C,  washed, and treated with glycine buffers of pH 
2.8,  3.3,  3.8, and 4.8, or with RPMI-Hepes (pH 7.4). The radioactivities of the 
acid-unremovable cell precipitate fractions and acid-removable buffer fractions 
were then  measured.  Treatment at pH  2.8,  3.3, or 3.8  removed >90%  of the 
surface-bound IL-2,  whereas treatment at pH  4.8  or 7.4  removed <10%  (Fig. 
2).  Acid treatment removed IL-2 from TL-Mor cells and PHA-treated PBL in 
the same way (data not shown). 
Internalization and Degradation oflL-2.  Ceil-bound IL-2 was rapidly internal- 
ized to be acid-unremovable when it was incubated at above 0°C, ILT-Yan cells 
treated  with  200  pM  ~esI-IL-2 at  0°C  were  washed  and  incubated at  various 
temperatures for the times indicated in  Fig.  3,  centrifuged, and the cell pellet 
was treated with acid buffer (pH 2.8). At 37°C, a rapid increase in internalized 
IL-2 was detected during the first 30 min of incubation, and >50%  of the ceil- 
bound  IL-2  was  internalized  within  the  first  10  rain,  whereas  the  amount  of 
surface-bound acid-removable IL-2 decreased proportionately. At lower temper- 
atures, the appearance of internalized IL-2 was slower, and at 0°C, no internal- 
ized IL-2 appeared within  120 min. The maximum levels of internalized IL-2 at 
37 and  27°C  were similar, and  were observed after incubation for 30 and  120 
min,  respectively.  After  reaching  a  maximum,  the  level  decreased  rapidly  at 
37 ° C. At 17 ° C, the internalized I L-2 increased linearly, and conversely, surface- 
bound  IL-2 decreased for at least  120  min.  Radioactivity was also detected in 
the culture supernatant:  it increased rapidly after at least 60 rain at 37°C,  but 
little at  the  lower  temperatures  (Fig.  3).  This  increase  in  radioactivity in  the 
culture supernatant at 37°C correlated quantitatively with decrease in internal- 
ized IL-2. The t,/~ of IL-2 internalization was estimated as <I0  min in the cells at 
37 °C. Similar kinetics of IL-2 internalization at 37°C was observed in TL-Mor 
TABLE  1 
Affinity and Number of lL-2-R 
Cell line 
High affinity  Low affinity 
Kd (pM)  Sites/cell  Kn (riM)  Sites/cell 
ILT-Yan  7.6+ 2.0  1,460_+  160  20.9_.+ 15.1 
TL-Mor  11.1 ±  1.9  1,630 +-- 440  38.1 -+ 11.9 
MT-1  UD*  UD  64.2 ± 4.7 
PBL*  16.8 ± 8.0  1,240 + 460  41.0 ± 37.0 
201,000 + 105.000 
326,000 + 61,000 
560,000 ± 283,000 
49,000 + 18,000 
* PBL were treated with PHA for 3 d. 
* U  D, undetectable. 554  INTERLEUKIN 2 INTERNALIZATION 
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FIGURE 2.  Removal  of surface-bound IL-2 by acid treatment. ILT-Yan  cells were incubated 
with 200 pM 1~51-IL-2 at 0oC for 30 rain, and washed. They  were then treated with chilled 
0,2 M glycine-HCI  buffer  at the indicated  pH, or with RPMI-Hepes  (pH 7.4). The radioactiv- 
ities of acid-removable buffer fractions (open bars) and acid-unremovable cell precipitate 
fractions (shaded bars) were counted. 
cells and PHA-treated PBL, but too little IL-2 bound to MT-1  cells for exami- 
nation of IL-2 internalization (Fig. 3). The reason for the small number of IL-2 
bound to MT-I cells is that the procedure used for treatment of cells with IL-2 
permitted IL-2 to bind to high-affinity receptors but not low-affinity receptors, 
because three washings of cells with PBS-BSA after treatment with IL-2 resulted 
in dissociation of IL-2 from low-affinity receptors, as shown in Fig. 4. 
For examination of the degradation of IL-2, the  culture supernatant, acid- 
removable, and acid-unremovable fractions of ILT-Yan cells  obtained in  the 
experiment at 37°C in Fig. 3 were treated with 10%  TCA (Fig. 5). Treatment 
with TCA resulted in scarcely any precipitation of radioactivity from the culture 
supernatant fraction but almost complete precipitation of the radioactivity in the 
acid-removable fraction. Most acid-unremovable radioactivity was also precipi- 
table from cells within 30 min of incubation, but subsequently became partially 
resistant to precipitation. These findings suggest that 12~I-IL-2 was internalized 
in the cells,  becoming acid-unremovable, and was then degraded to small TCA- 
soluble fragments that were released from the cells, resulting in radioactivity in 
the culture supernatant. Similar degradation of IL-2 was detected with TL-Mor 
cells and PHA-treated PBL (data not shown). The t,/~  of IL-2 degradation was 
estimated as 60-80 rain in these cells. 
Light-microscopic autoradiography confirmed that the acid-unremovable cell- 
associated IL-2 is intracellular IL-2 internalized by the cells.  ILT-Yan cells were 
treated with [3H]IL-2 at 0°C for 30 rain, washed, and incubated at 37°C for the 
indicated times, and  then  subjected to  microscopic autoradiography (Fig.  6). 
Localization  of the  grains  observed  in  Fig.  6  was  graphed  in  Fig.  7,  and 
nonspecific binding of [3H]IL-2 was calculated to be <10% of the total binding 
by adding unlabeled IL-2 (data not shown). Most of the grains of [~H]IL-2 were FUJll  ET  AL. 
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FIGURE 3.  Temperature-dependent appearance of internalized IL-2. (A) ILT-Yan cells were 
125  o  incubated with  200  pM  1-1L-2  at  0  C  for  30  rain,  washed,  then incubated at various 
temperatures for  the  indicated times. They  were  then centrifuged and were  treated with 
chilled 0.2 M glycine buffer, pH 2.8, for  10 rain. The radioactivities of culture supernatants 
(&), acid-removable glycine buffer fractions (B) and acid-unremovable cell precipitate fractions 
(0)  were  counted.  The  sum  of the  counts in  these  three  fractions is  shown  as  the  total 
radioactivity (O).  (B) TL-Mor,  PHA-treated PBL and MT-1  cells were examined similarly at 
37°C. 556  INTERLEUKIN  2  INTERNALIZATION 
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F~CUR[ 4.  Scatchard  plot analysis  of z2~I-IL-2-binding after  washing cells•  ILT-Yan  cells 
were treated with ~251-IL-2 at 0°C, then washed three times with PBS-BSA (@). ILT-Yan cells 
were treated with ~51-1L-2 at 0°C, and the cell-associated ~eSl-IL-2 was separated by centrif- 
ugation with  1 M sucrose cushion without washing, as described in the IL-2 binding assay of 
•  "rl  "I]  125  Materials. and, Methods (U).5 Specific bl  d=  g of  1-1L-2, to cells were calculated by subtracting 
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FIGURE 5.  Degradation of ]251-IL-2. The acid-unremovable (A), acid-removable (B) fractions, 
and culture supernatant  (C), of ILT-Yan cells obtained in the experiment in Fig. 3 at 37°C 
were treated with 1  0% TCA overnight at 4 °C. The TCA-soluble (O) and total (TCA-so]uble 
+ TCA-insoluble) (@) radioactivities were counted. 
seen near the cell surface at 0  min of incubation.  After incubation  for 5  min, 
about half the grains had moved to the cytoplasm, and  10% of the grains were 
seen  in  the  nucleus.  After  60  rain  incubation,  the  numbers  of cell  surface- FUJII  ET  AL.  557 
FZ~;URE 6.  Light-microscopic autoradiographs  of IL-2  internalized by cells.  ILT-Yan cells 
were treated with 3H-labeled IL-2 at 0°C for 30 rain. They were then washed and incubated 
at  37°C for 0  rain  (a),  5  rain (b), 30  rain (c), 60 min (d), and  120 rain (e), and prepared  for 
light-microscopic autoradiography.  Arrowheads indicate silver grains in the nucleus (~) and 
cytoplasm or cell surface (~), and the intracellular dense organelles (>). 
associated grains had decreased further, while grains in the cytoplasm and nucleus 
had increased to 64 and  18%, respectively. After 120 min incubation, grains in 
the  nucleus had  increased further to  24%,  while  those  in  the cytoplasm had 
slightly decreased. Grains on the cell surface had ceased to decrease, and had 
increased slightly at  120  rain of incubation. These changes of cell-surface IL-2 
and  intracellular  IL-2  demonstrated by autoradiography correlated well with 
changes of acid-removable and acid-unremovable IL-2, respectively. 
Discussion 
We  (39)  and  others  (9)  examined  the affinities and  densities of IL-2-R  on 
various HTLV-I-carrying human cell lines.  As shown  in  Table  I,  the cell line 
MT-1 is unique in having abundant low-affinity IL-2-R but very few high-affinity 
receptors.  IL-2-dependent  T  cell  lines,  such  as  ILT-Yan,  and  immortalizing 558  INTERLEUKIN 2  INTERNALIZATION 
100 
0 5  30  60  120 
Incubation  time  (rnin) 
FIGURE  7.  Subce|lular localization of internalized 1L-2. >500  silver grains of [SHILL-2 in 
Fig. 6 were counted at each time, and their subcellular locations  were classified  as cell surface 
(O), cytoplasmic  ((3) and nuclear (I). 
transformed  T  cell  lines,  such  as  TL-Mor,  were  established  from  HTLV-I- 
infected  T  cells,  and  these  cell  lines,  like  other  HTLV-I-carrying  cell  lines, 
express normal ranges of high-affinity IL-2-R, but more low-affinity IL-2-R than 
PHA-treated  normal  PBL  (39).  Using  these  HTLV-I-carrying  cell  lines  and 
PHA-treated normal PBL, we examined the internalization and degradation of 
IL-2. First, we confirmed that surface-bound 'z~I-IL-2, but not internalized ~sI- 
IL-2, can be removed from cells by acid treatment. >90% of the cell-bound IL- 
2 was dissociated by treatment with acid buffer pH 3.8 or below at 0°C, but IL- 
2  internalized into cells at 37°C became acid unremovable. A  kinetic study by 
microscopic autoradiography on [3H]IL-2-treated cells clearly showed that the 
zcid-unremovable IL-2 is internalized, intracellular IL-2. IL-2 internalization is 
a rapid reaction that is dependent on temperature. >50% of the IL-2 bound to 
high-affinity receptors was internalized within 10 min when the cells were shifted 
from 0 to 37°C. Since Robb and Lin (30) reported that IL-2 internalization by 
murine T  cells has a  t,/~ of 27 min, IL-2 internalization by human T  cells seems 
to be slightly rapid. 
At 37°C, decrease of internalized IL-2 was observed after  1 h  of incubation, 
which  could  be  mainly due  to  degradation  of the  IL-2  and  excretion  of its 
products  into the culture supernatant,  because the radioactivity in the culture 
supernatant that was not precipitated with  10%  TCA increased inversely with 
decrease  in the amount of internalized  '25I-IL-2.  The  tw  of IL-2 degradation 
was estimated as 60-80  min in the T  cells we observed.  In murine cells, the t,~ 
of IL-2 degradation was reported to be 78 rain (30), indicating that there is no 
significant difference in the tv~ of IL-2 degradation in human and murine T  cells. 
Robbet al. (11,  30) suggested that, as IL-2 degradation is inhibited by chloro- FUJII  ET  AL.  559 
quine, which is known to inhibit lysosomal enzymes, the internalized IL-2 could 
be degraded in lysosomes. The degradations of other ligands, such as EGF and 
insulin in lysosomes has also been reported (16-20). Therefore, the IL-2 bound 
to  high-affinity receptors was  probably  mainly internalized  and  then  quickly 
degraded in lysosomes. 
When  cells  treated  with  IL-2,  even  at  high  concentrations,  were  washed 
extensively, IL-2  bound to high-affinity receptors, but not appreciably to low- 
affinity receptors (Fig. 4). We also examined IL-2 internalization without washing 
the cells, to determine whether low-affinity receptors also mediate internalization 
of IL-2.  In this experiment, ~5%  of IL-2 bound to MT-1  cells, which express 
only low-affinity receptors,  became acid-unremovable. This acid-unremovable 
IL-2  could  be  due  to  fluid-phase pinocytosis,  but  not  due  to  internalization, 
because treatment of the cells with sodium azide in glucose-free medium did not 
inhibit appearance of the acid-unremovable IL-2. On the other hand, internali- 
zation mediated by high-affinity receptors was completely inhibited by the same 
treatment.  2 Therefore, internalization of IL-2  seems to be mediated by high- 
affinity receptors. Smith and Cantreil (12), and Depper et al. (13) suggested that 
the cell growth signal of IL-2 can be transduced from high-affinity, but not low- 
affinity receptors. [~H]Thymidine uptake by PHA-treated PBL was maximal in 
the presence of 200 pM IL-2, which saturates high- but not low-affinity receptors, 
and decrease of low-affinity receptors did not affect [3H]thymidine uptake of 
PHA-treated PBL. It is possible that IL-2 internalization mediated by the high- 
affinity receptors is essential for the transduction of growth signal induced by 
IL-2,  although  further  study  is  necessary to  obtain  direct evidences for  the 
contribution of IL-2 internalization to the signal transduction from IL-2-R. 
Light-microscopic autoradiography confirmed the internalization of IL-2. Fur- 
thermore, some IL-2 was detected in the nucleus. Intranuclear accumulation of 
EGF (40),  nerve growth factor (41), and insulin (42) have also been reported, 
although the biological significance of the intranuclear accumulation of these 
ligands  or  receptors is  unknown.  IL-2  or  IL-2-R  may be  transferred  to  the 
nucleus, where they function directly to elicit the growth signal.  We are now 
examining details of the localization of internalized IL-2 and IL-2-R and their 
fate in the cells. 
Summary 
Receptor-mediated internalization and degradation of IL-2 were investigated 
in cell lines carrying human T  cell leukemia/lymphoma (lymphotrophic) virus 
type I (HTLV-I) and PHA-treated normal PBL. The HTLV-I-carrying cell lines 
ILT-Yan and TL-Mor, and the PBL expressed both high- and low-affinity IL-2- 
R. However, another HTLV-I-carrying T  cell line, MT-1, expressed mainly low- 
affinity receptors. >50% of the IL-2 bound to high-affinity receptors was inter- 
nalized within 10 rain when these cells were incubated at 37 ° C. The internalized 
IL-2 was rapidly degraded and the products were excreted into the culture fluid. 
The t,/2  of IL-2 degradation in these cells was estimated as 60-80 min at 37°C. 
The internalization and degradation of IL-2 were both temperature dependent. 
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Light-microscopic  autoradiography  with  ~H-labeled  IL-2  confirmed  the  inter- 
nalization of IL-2, and suggested that some IL-2 might be carried to the nucleus. 
We thank Dr. T. Sato for computer analysis and Dr. M. Nakamura for helpful discussion. 
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